The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Novartis AG

NYSE: NVS
Last

(U.S.) $74.33

Today's change0.00 0.00%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Novartis AG

NYSE: NVS
Last

(U.S.) $74.33

Today's change0.00 0.00%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Novartis AG closed at (U.S.)$74.33.

Over the last five days, shares have lost 4.67% and are down 13.61% for the last year to date. This security has underperformed the S&P 500 by 15.14% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $74.33
  • High--
  • Low--
  • Bid / Ask(U.S.) $72.85 / (U.S.) $72.95
  • YTD % change-13.61%
  • Volume0
  • Average volume (10-day)2,739,397
  • Average volume (1-month)2,349,180
  • Average volume (3-month)2,026,324
  • 52-week range(U.S.) $73.97 to (U.S.) $106.84
  • Beta0.62
  • Trailing P/E25.85×
  • P/E 1 year forward15.45×
  • Forward PEG2.18×
  • Indicated annual dividend(U.S.) $2.67
  • Dividend yield3.59%
  • Trailing EPS(U.S.) $2.88
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.96%

Based on its net profit margin of 13.96%, Novartis AG is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue12,48512,89612,17413,354
Total other revenue--------
Total revenue12,48512,89612,17413,354
Gross profit8,1448,5598,2238,938
Total cost of revenue4,3414,3373,9514,416
Total operating expense10,25110,6159,38911,003
Selling / general / administrative3,4413,5963,2683,965
Research & development2,1532,1632,0442,537
Depreciation / amortization101210--
Interest expense (income), net operating--------
Unusual expense (income)28132190--
Other operating expenses, total251862685
Operating income2,2342,2812,7852,351
Interest income (expense), net non-operating-154-164-179-188
Gain (loss) on sale of assets--------
Other--------
Income before tax2,1692,1562,6782,756
Income after tax1,8121,8562,3062,448
Income tax, total357300372308
Net income1,8881,83613,0051,491
Total adjustments to net income--------
Net income before extra. items1,8051,8542,3062,452
Minority interest-7-204
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,8051,8542,3062,452
Inc. avail. to common incl. extra. items1,8881,83613,0051,491
Diluted net income1,8881,83613,0051,491
Dilution adjustment0000
Diluted weighted average shares2,4382,4482,4462,458
Diluted EPS excluding extraordinary itemsvalue per share0.740.760.941.00
Dividends per sharevalue per share0.000.000.002.76
Diluted normalized EPSvalue per share0.840.870.971.06